(Total Views: 293)
Posted On: 10/07/2020 12:05:49 PM
Post# of 47

$CTXR News Article - Citius Pharmaceuticals Signs an Exclusive Worldwide Licensing Agreement with Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory Respiratory Conditions including COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) https://marketwirenews.com/news-releases/citi...38966.html


My Twitter: WhyteStocks